T. Perez

发表

Clinical COPD phenotypes: a novel approach using principal component and cluster analyses

D. Caillaud, N. Roche, I. Tillie‐Leblond, 2010, European Respiratory Journal.

Prevalence and management of chronic breathlessness in COPD in a tertiary care center

D. Caillaud, C. Morélot-Panzini, N. Roche, 2019, BMC Pulmonary Medicine.

Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities

N. Roche, P. Burgel, P. Chanez, 2009, European Respiratory Review.

High quality standards for a large-scale prospective population-based observational cohort: Constances

N. Roche, M. Zins, M. Goldberg, 2016, BMC Public Health.

Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2

C. Schumann, F. Sciurba, F. Herth, 2020, International journal of chronic obstructive pulmonary disease.

Impact of chronic airflow obstruction in a working population

N. Roche, T. Perez, F. Neukirch, 2008, European Respiratory Journal.

Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease

D. Caillaud, N. Roche, P. Burgel, 2015, International journal of chronic obstructive pulmonary disease.

Impact of comorbidities on COPD-specific health-related quality of life.

D. Caillaud, N. Roche, I. Court-Fortune, 2013, Respiratory Medicine.

Defining the “Frequent Exacerbator” Phenotype in COPD: A Hypothesis‐Free Approach

N. Roche, I. Tillie‐Leblond, B. Housset, 2017, Chest.

Is it really time to look at distal airways to improve asthma phenotyping and treatment?

T. Perez, 2011, European Respiratory Journal.

Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities

D. Caillaud, N. Roche, I. Court-Fortune, 2019, International journal of chronic obstructive pulmonary disease.

[COPD and inflammation: statement from a French expert group. Phenotypes related to inflammation].

P. Devillier, T. Similowski, N. Roche, 2011, Revue des maladies respiratoires.

Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?

D. Caillaud, N. Roche, I. Court-Fortune, 2014, European Respiratory Journal.

Title: Real-life use of inhaled corticosteroids in COPD patients vs. GOLD proposals: a paradigm shift in GOLD 2011? Authors:

D. Caillaud, N. Roche, I. Court-Fortune, 2013 .

Impact of current cough on health-related quality of life in patients with COPD

D. Caillaud, N. Roche, I. Court-Fortune, 2016, International journal of chronic obstructive pulmonary disease.

Association of chronic nasal symptoms with dyspnoea and quality‐of‐life impairment in chronic obstructive pulmonary disease

D. Caillaud, N. Roche, I. Court-Fortune, 2014, Respirology.

Association between occupational exposure and the clinical characteristics of COPD

D. Caillaud, N. Roche, I. Court-Fortune, 2012, BMC Public Health.

FEV1/FVC and FEV1 for the assessment of chronic airflow obstruction in prevalence studies: do prediction equations need revision?

N. Roche, T. Perez, F. Neukirch, 2008, Respiratory medicine.

High prevalence of COPD symptoms in the general population contrasting with low awareness of the disease.

N. Roche, T. Perez, P. Carré, 2011, Revue des maladies respiratoires.

The Effect of an Information Leaflet upon Knowledge and Awareness of COPD in Potential Sufferers

N. Roche, T. Perez, P. Carré, 2008, Respiration.

Long‐term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: Prospective analysis from the French Pompe Registry

F. Chapon, T. Perez, G. Bassez, 2020, Journal of inherited metabolic disease.

Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes

A. Valipour, D. Slebos, P. Shah, 2020, Respiratory Research.

Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2

F. Sciurba, D. Slebos, K. Darwiche, 2020 .

[Maximal isometric voluntary quadriceps strength assessment in COPD].

B. Wuyam, T. Perez, S. Vergès, 2014, Revue des maladies respiratoires.

Position paper of the French Society of Respiratory Diseases regarding pharmacological treatment optimization for stable COPD in 2021.

P. Devillier, C. Morélot-Panzini, N. Roche, 2022, Respiratory medicine and research.

[Validation study of the BDI/TDI scores in chronic obstructive pulmonary disease].

N. Roche, T. Perez, B. Detournay, 2009, Revue des maladies respiratoires.

COPD_A_295381 1275..1284

D. Caillaud, N. Roche, I. Court-Fortune, 2021 .

Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic

J. Muir, P. Devillier, A. Didier, 2017, European Respiratory Journal.

[Mini-spirometry: a relevant tool for the screening of COPD in general practice?].

T. Perez, C. Bizon, 2012, Revue des maladies respiratoires.

Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD

T. Perez, M. Brun, A. Tonnel, 2008, International journal of chronic obstructive pulmonary disease.

Update on the roles of distal airways in asthma

C. Delacourt, M. Humbert, P. Devillier, 2009, European Respiratory Review.

Clinical COPD phenotypes identified by cluster analysis: validation with mortality

D. Caillaud, N. Roche, I. Tillie‐Leblond, 2012, European Respiratory Journal.

Is CCL18 a potential biomarker of type-2 asthma endotypes?

P. Berger, J. Giovannelli, P. Chanez, 2020, The Journal of asthma : official journal of the Association for the Care of Asthma.

Computed tomographic airway morphology after targeted lung denervation treatment in COPD.

F. Herth, R. Eberhardt, J. Annema, 2022, Respiratory medicine.

[Guide for follow-up of patients with SARS-CoV-2 pneumonia. Management proposals developed by the French-language Respiratory Medicine Society. Version of 10 May 2020].

F. Costes, T. Perez, L. Plantier, 2020, Revue des maladies respiratoires.

Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis

P. Berger, T. Perez, T. Soumagne, 2017, European Respiratory Journal.

Lung capillary blood volume and membrane diffusion in idiopathic interstitial pneumonia.

T. Perez, B. Wallaert, L. Wémeau-Stervinou, 2012, Respiratory medicine.

Small airways diseases, excluding asthma and COPD: an overview

P. Devillier, A. Didier, N. Roche, 2013, European Respiratory Review.

Beyond corticosteroids: future prospects in the management of inflammation in COPD

P. Devillier, T. Similowski, N. Roche, 2011, European Respiratory Review.

Update on the roles of distal airways in COPD

P. Devillier, A. Didier, N. Roche, 2011, European Respiratory Review.

How can we minimise the use of regular oral corticosteroids in asthma?

P. Chanson, P. Devillier, A. Didier, 2020, European Respiratory Review.

Properties of the COPD assessment test in a cross-sectional European study

P. Kardos, T. Perez, P. Jones, 2011, European Respiratory Journal.

Relationship between gender and survival in a real-life cohort of patients with COPD

D. Caillaud, N. Roche, I. Court-Fortune, 2019, Respiratory Research.

Validity, reliability, and responsiveness of a new shortVisual Simplified Respiratory Questionnaire (VSRQ©) for health-related quality of life assessment in chronic obstructive pulmonary disease

T. Perez, B. Arnould, I. Guillemin, 2008, International journal of chronic obstructive pulmonary disease.

Asthma–COPD overlap syndrome (ACOS) vs ‘pure’ COPD: a distinct phenotype?

D. Caillaud, N. Roche, I. Court-Fortune, 2017, Allergy.

Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects.

Nicolas Roche, Philippe Carré, D. Caillaud, 2009, Chest.

P. Jones, T. Perez, P. Jones, 2011, Respiratory medicine.

Impact of gender on COPD expression in a real-life cohort

Nicolas Roche, D. Caillaud, N. Roche, 2014, Respiratory Research.

Undiagnosed airflow limitation in patients at cardiovascular risk.

N. Roche, J. Ferrières, V. Bongard, 2011, Archives of cardiovascular diseases.

Undiagnosed Airflow Limitation In Patients At Cardiovascular Risk

N. Roche, J. Ferrières, V. Bongard, 2011, ATS 2011.

Physiologic correlates of dyspnea in patients with morbid obesity

F. Pattou, T. Perez, R. Matran, 2007, International Journal of Obesity.

The multidimensional nature of dyspnoea in amyotrophic lateral sclerosis patients with chronic respiratory failure: Air hunger, anxiety and fear.

P. Devillier, C. Morélot-Panzini, T. Similowski, 2018, Respiratory medicine.

Real-life assessment of the multidimensional nature of dyspnoea in COPD outpatients

P. Devillier, A. Didier, C. Morélot-Panzini, 2016, European Respiratory Journal.

Multidimensional evaluation of dyspnea in COPD: An observational field-study

P. Devillier, A. Didier, C. Morélot-Panzini, 2014 .

Prevalence and reversibility of lung hyperinflation in adult asthmatics with poorly controlled disease or significant dyspnea

P. Devillier, P. Chanez, T. Perez, 2016, Allergy.

Assessing the applicability of the new Global Lung Function Initiative reference values for the diffusing capacity of the lung for carbon monoxide in a large population set

T. Perez, S. Hulo, J. Edmé, 2021, PloS one.

[COPD and inflammation: Statement from a French expert group. How to treat inflammation?].

P. Devillier, T. Similowski, N. Roche, 2011, Revue des maladies respiratoires.

[Prevention of COPD exacerbation: a fundamental challenge].

T. Similowski, N. Roche, I. Durand-zaleski, 2012, Revue des maladies respiratoires.

Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial

C. Schumann, F. Sciurba, F. Herth, 2019, American journal of respiratory and critical care medicine.

COPD beyond proximal bronchial obstruction: phenotyping and related tools at the bedside

P. Chanez, T. Perez, A. Bourdin, 2019, European Respiratory Review.

Burden and Characteristics of Severe Chronic Hypoxemia in a Real-World Cohort of Subjects with COPD

D. Caillaud, N. Roche, I. Court-Fortune, 2021, International journal of chronic obstructive pulmonary disease.

Validity, reliability, and responsiveness of a new shortVisual Simplified Respiratory Questionnaire (VSRQ©) for health-related quality of life assessment in chronic obstructive pulmonary disease

T. Perez, B. Arnould, I. Guillemin, 2009, International journal of chronic obstructive pulmonary disease.

Validity , reliability , and responsiveness of a new short Visual Simpli fi ed Respiratory Questionnaire ( VSRQ © ) for health-related quality of life assessment in chronic obstructive pulmonary disease

T. Perez, B. Arnould, I. Guillemin, 2008 .

Small airway impairment in moderate to severe asthmatics without significant proximal airway obstruction.

P. Devillier, P. Chanez, T. Perez, 2013, Respiratory medicine.

Safety and Dose Study of Targeted Lung Denervation in Moderate/Severe COPD Patients

A. Valipour, D. Slebos, P. Shah, 2019, Respiration.

Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD

D. Caillaud, N. Roche, I. Court-Fortune, 2017, International journal of chronic obstructive pulmonary disease.

Air trapping in mild and moderate asthma: effect of inhaled corticosteroids.

F. Laurent, J. Tunon-de-lara, P. Chanez, 2007, The Journal of allergy and clinical immunology.

The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis

T. Perez, R. Matran, V. Danel-Brunaud, 2009, European Respiratory Journal.

The BORG dyspnea score : a relevant clinical marker of inspiratory muscle weakness in Amyotrophic Lateral Sclerosis

T. Perez, R. Matran, V. Danel-Brunaud, 2009 .

[Research in amyotrophic lateral sclerosis: what is new in 2009?].

T. Perez, A. Echaniz-Laguna, P. Cintas, 2010, Revue neurologique (Paris).

[The gap between the high impact and low awareness of COPD in the population].

N. Roche, T. Perez, P. Carré, 2009, Revue des maladies respiratoires.

A double-blind, randomized, sham-controlled study of Targeted Lung Denervation in patients with moderate to severe COPD

C. Schumann, F. Herth, A. Valipour, 2018, Interventional Pulmonology.

Dyspnea-induced Limitation (DYSLIM), a new self-administered concise questionnaire to evaluate dyspnea-related activity limitation in chronic respiratory diseases.

N. Roche, P. Burgel, T. Perez, 2023, Respiratory medicine.

Real-life use of long-acting antimuscarinic agents following their approval for COPD treatment

D. Caillaud, N. Roche, I. Court-Fortune, 2015, European Respiratory Journal.

Patient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe.

T. Perez, P. Jones, P. Kardos, 2012, Primary care respiratory journal : journal of the General Practice Airways Group.

[COPD and quality of life: impact of the disease in primary care in France].

T. Perez, C. Pribil, P. Serrier, 2013, Revue des maladies respiratoires.

[Comments on the open letter to the GOLD committee].

T. Perez, A. Chambellan, 2010, Revue des maladies respiratoires.

[Epidemiology and COPD screening in France. Workshop from the Société de Pneumologie de Langue Française (SPLF)].

A. Cuvelier, N. Roche, T. Perez, 2014, Revue des maladies respiratoires.

Asthma-COPD overlap syndrome (ACOS) versus "pure" COPD: A distinct phenotype?

D. Caillaud, N. Roche, I. Court-Fortune, 2016 .

[Pharmacological treatment optimisation in patients with stale COPD. Position of the French-language Respiratory Society. 2021 Update].

P. Devillier, N. Roche, B. Delclaux, 2021, Revue des maladies respiratoires.